Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Sava RI, Pepine CJ, March KL. Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy. J Clin Med. 2020 Jan 16;9(1). pii: E241. doi: 10.3390/jcm9010241. Review. PubMed PMID: 31963368.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study
Journal Publication Name
- Journal of Clinical Medicine
Literature Type
- PCORI Research